Necon 0.5/35 (Watson Pharma, Inc.)
Welcome to the PulseAid listing for the Necon 0.5/35 drug offered from Watson Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Watson Pharma, Inc. |
NON-PROPRIETARY NAME: | Norethindrone and Ethinyl Estradiol Tablets |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1987-01-29 |
END MARKETING DATE: | 0000-00-00 |
Necon 0.5/35 HUMAN PRESCRIPTION DRUG Details:
Item Description | Necon 0.5/35 from Watson Pharma, Inc. |
LABELER NAME: | Watson Pharma, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 1987-01-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52544-550_ea79aa51-8330-47f6-ad72-d6976124211c |
PRODUCT NDC: | 52544-550 |
APPLICATION NUMBER: | ANDA070686 |